Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker.

Human pathology - 1 Apr 2017

Meguro Shiori, Akamatsu Taisuke, Matsushima Sayomi, Kosugi Isao, Kawasaki Hideya, Arai Yoshifumi, Baba Satoshi, Tsuchida Takashi, Shido Yoji, Suda Takafumi, Iwashita Toshihide

Abstract excerpt

Our aims were to identify pericyte-specific markers for the analysis of formalin-fixed, paraffin-embedded human tissue samples, and to characterize perivascular myoid cell neoplasms phenotypically. Previously identified pericyte markers failed to distinguish pericytes from other cellular types, such as vascular smooth muscle cells (vSMCs) and fibroblasts, in immunohistochemistry analysis. However, we compared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calmodulin-Binding Proteins
Share to Cell Lineage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorescent Antibody Technique

Share to Myocytes, Smooth Muscle

Share to Myosin Type I

Share to Pericytes

Share to Soft Tissue Neoplasms

Source

Identifiers

PMID: 28088345
DOI: 10.1016/j.humpath.2016.12.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker.PMID 28088345Read ↗

PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors.Semantic proximity Read ↗

PDGFRB and NOTCH3 mutations are detectable in a wider range of pericytic tumors, including myopericytomas, angioleiomyomas, glomus tumors, and their combined tumorsSemantic proximity Read ↗

A Molecular Reappraisal of Glomus Tumors and Related Pericytic Neoplasms With Emphasis on NOTCH-gene FusionsSemantic proximity Read ↗

Pericytic mimicry in well-differentiated liposarcoma/atypical lipomatous tumor.Semantic proximity Read ↗

The genetics of vascular tumours: an update.Semantic proximity Read ↗

Characterization of Human Pericyte Phenotype by Immunohistochemistry.Semantic proximity Read ↗

Pericytes and Lung Vascular Remodeling.Semantic proximity Read ↗

Angiomatoid fibrous histiocytoma occurring at distal/acral extremity sites: clinicopathological and molecular study of 26 cases highlighting frequent myxoid histology and site-dependent genotypic variation.Semantic proximity Read ↗

Novel NOTCH3 alteration expanding the molecular spectrum of pericytic tumours: report of two cases.Semantic proximity Read ↗

Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.Semantic proximity Read ↗

Malignant vascular tumors--an update.Semantic proximity Read ↗

A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.